IXICO PLC (IXI)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
8.50p
Buy
9.50p
0.50p (+5.56%)
IXICO PLC is engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies.
Prices updated at 08 May 2025, 07:55 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
| Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
|---|---|---|---|---|---|
| 2024 | 47.02 | -36.46 | -34.70 | -27.64 | -2m |
| 2023 | 49.06 | -20.29 | -17.67 | -10.61 | -1m |
| 2022 | 60.66 | 10.51 | 11.94 | 18.01 | 2m |
| 2021 | 65.55 | 11.89 | 16.45 | 18.80 | 2m |
| 2020 | 66.58 | 8.83 | 9.99 | 13.79 | 1m |
| 2019 | 65.36 | 5.17 | 5.71 | 6.32 | 0m |
| 2018 | 58.82 | -14.57 | -12.38 | -11.75 | -1m |
| 2017 | 56.44 | -33.49 | -37.49 | -28.80 | -1m |
| 2016 | 48.59 | -72.52 | -64.84 | -61.90 | -2m |
Valuation data table
| Year | Price / Sales | Price earnings | Price / Cash flow |
|---|---|---|---|
| 2025 | 0.75 | - | - |
| 2024 | 0.98 | - | - |
| 2023 | 0.91 | - | 20.00 |
| 2022 | 1.50 | 12.56 | 9.09 |
| 2021 | 3.29 | 19.23 | 49.34 |
| 2020 | 5.11 | 51.25 | 25.19 |
| 2019 | 5.60 | 98.37 | - |
| 2018 | 1.47 | - | 21.86 |
| 2017 | 2.39 | - | - |
| 2016 | 2.47 | - | - |
| 2015 | - | - | - |
Price/Forward earnings (YTD)
-4.29
Returns
Debt profile
Returns data table
| Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
|---|---|---|---|
| 2024 | -16.55 | -19.15 | -19.06 |
| 2023 | -8.52 | -9.85 | -10.02 |
| 2022 | 7.14 | 8.61 | 8.38 |
| 2021 | 11.42 | 14.46 | 14.07 |
| 2020 | 8.30 | 10.97 | 10.82 |
| 2019 | 4.11 | 5.67 | 5.65 |
| 2018 | -9.00 | -13.34 | -13.41 |
| 2017 | -30.16 | -46.87 | -46.87 |
| 2016 | -42.72 | -64.43 | -64.45 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.18 |
| 2023 | 1.14 |
| 2022 | 1.17 |
| 2021 | 1.24 |
| 2020 | 1.30 |
| 2019 | 1.35 |
| 2018 | 1.41 |
| 2017 | 1.68 |
| 2016 | 1.47 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
